
Providing reusable, verifiable, and scalable mRNA drug development and industrialization capabilities for complex and evolving disease challenges.









We scale mRNA impact through three platform-enabled domains: infectious disease vaccine engineering, therapeutic immunology interventions, and durable therapeutic products for long-term dosing—forming a sustainable system from R&D to translation.

Transforming public health and tackling major diseases requires more than a single successful program—it takes an mRNA platform that can respond rapidly, manufacture reliably, and iterate continuously. That is why we are building long-term foundational capabilities with talent across molecular biology, delivery and materials, process development and QC, and clinical translation.
Join us to help make mRNA a global health infrastructure—accessible, scalable, and affordable for more people.